Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Capital Markets Event and Webcast

Posted on: 30 Apr 18

ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce that it will be hosting a capital markets event on the Company’s exosome nanomedicine platform on Thursday 17 May 2018. The event, for analysts and institutional investors, will take place at 2.30pm at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.


ReNeuron is a leader in the field of exosomes; this event will provide an opportunity for attendees to learn more about the continued progress being made in the Company’s exosome programme, which is based on exosomes secreted by the Company’sproprietary CTX stem cell line.


The event will be hosted by Olav Hellebø, CEO of ReNeuron, and will include presentations by Dr Randolph Corteling, the Company’s Head of Research, and Dr Stephen J Gould, a key opinion leader from the Johns Hopkins School of Medicine, Baltimore, Maryland. Dr Gould is a professor of biological chemistry, has published more than 100 scientific papers, and serves as the president of the American Society of Exosomes and Microvesicles.


The Company will not be providing any new material information.


Webcast details


To access a webcast of the event, please log on to the following web address approximately 10 minutes before 2.30pm on the day of the event:


A recording of the presentation will be made available on ReNeuron’s website,


Editor's Details

Mike Wood

Last updated on: 30/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.